<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Medications for acute vertigo</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Medications for acute vertigo</h1>
<div class="graphic"><div class="figure"><div class="ttl">Medications for acute vertigo</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Dose as-needed</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Orally administered agents:</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Antihistamines, first-generation</td> </tr> <tr> <td class="indent2">Dimenhydrinate</td> <td>50 mg every 4 to 6 hours</td> </tr> <tr> <td class="indent2">Diphenhydramine</td> <td>25 to 50 mg every 4 to 6 hours (maximum daily dose 200 to 300 mg)</td> </tr> <tr> <td class="indent2">Meclizine</td> <td>12.5 to 50 mg every 6 to 12 hours (maximum daily dose 100 mg)</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Benzodiazepines</td> </tr> <tr> <td class="indent2">Alprazolam</td> <td>0.5 mg immediate release every 8 hours</td> </tr> <tr> <td class="indent2">Clonazepam</td> <td>0.25 to 0.5 mg every 8 to 12 hours</td> </tr> <tr> <td class="indent2">Diazepam</td> <td>1 to 5 mg every 12 hours</td> </tr> <tr> <td class="indent2">Lorazepam</td> <td>1 to 2 mg every 8 hours</td> </tr> <tr> <td class="indent1" colspan="2"><em>Benzodiazepines should not be used for more than 2 to 3 days for acute vertigo treatment</em></td> </tr> <tr> <td class="subtitle3_left" colspan="2">Antiemetics*</td> </tr> <tr> <td class="indent2">Metoclopramide</td> <td>5 to 10 mg every 6 hours</td> </tr> <tr> <td class="indent2">Ondansetron<sup>¶</sup></td> <td>4 mg every 8 to 12 hours</td> </tr> <tr> <td class="indent2">Prochlorperazine</td> <td>5 to 10 mg every 6 hours</td> </tr> <tr> <td class="indent2">Promethazine</td> <td>12.5 to 25 mg every 4 to 6 hours</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Parenterally administered agents for acute emergency ward use:<sup>Δ</sup></td> </tr> <tr> <td class="subtitle3_left" colspan="2">Antihistamines, first-generation</td> </tr> <tr> <td class="indent2">Diphenhydramine</td> <td>10 to 50 mg IV</td> </tr> <tr> <td class="indent2">Dimenhydrinate</td> <td>50 mg IV</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Antiemetics*</td> </tr> <tr> <td class="indent2">Metoclopramide</td> <td>10 mg IV</td> </tr> <tr> <td class="indent2">Ondansetron<sup>¶</sup></td> <td>4 to 8 mg IV</td> </tr> <tr> <td class="indent2">Prochlorperazine</td> <td>2.5 to 10 mg IV</td> </tr> <tr> <td class="indent2">Promethazine</td> <td>12.5 to 25 mg IM or IV (vesicant, use caution with IV administration; refer to Lexicomp drug monograph included within UpToDate)</td> </tr> </tbody></table></div><div class="graphic_lgnd">Medications for treatment of acute vertigo. Doses listed are for non-volume depleted adult or adolescent patients with normal renal function. These agents may require dose adjustment in patients with reduced organ function (eg, kidney or cardiac disease) and in older persons. For specific recommendations, refer to the Lexicomp drug monographs included within UpToDate.</div><div class="graphic_footnotes"><p>IV: intravenous; IM: intramuscular.</p>
<p>* Rare adverse cardiac reactions have been described with most antiemetics, particularly following parenteral use. These agents should be avoided in patients with known QT interval prolongation or other risk factors for torsades de pointes (TdP; eg, hypomagnesemia, hypokalemia). Refer to topic review of acquired long QT syndrome, section on drug-induced TdP within UpToDate. Phenothiazines and metoclopramide can cause extrapyramidal side effects (eg, akathisia, dystonia), particularly with parenteral use. Refer to accompanying text.</p>
<p>¶ Other serotonin 5HT3 antagonist antiemetics (eg, dolasetron, granisetron) may be used if ondansetron is not available.</p>
Δ If IV access is unavailable, these agents may be administered IM. However, with the exception of promethazine, IM use is not preferred due to injection site pain.</div><div id="graphicVersion">Graphic 68052 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
